We estimate that the CEO of Apogee Therapeutics, Inc. ($APGE), Michael Henderson, M.D., received a compensation of $1,291,500 in 2025. This is a decrease of -922.66% from an estimated $13,207,682 in 2024.
These estimates are based on a new DEF14A filing, filed with the SEC on April 24, 2026. Note that parsing errors may occur.
You can track $APGE on Quiver Quantitative's $APGE stock dashboard.
$APGE Stock Insider Trading Activity
$APGE Stock insiders have traded $APGE stock on the open market 63 times in the past 6 months. Of those trades, 0 have been purchases and 63 have been sales.
Here’s a breakdown of recent trading of $APGE stock by insiders over the last 6 months:
- FUNDS MANAGEMENT LLC FAIRMOUNT sold 1,750,000 shares for an estimated $133,525,000
- MICHAEL THOMAS HENDERSON (Chief Executive Officer) has made 0 purchases and 23 sales selling 160,000 shares for an estimated $11,804,673.
- CARL DAMBKOWSKI (Chief Medical Officer) has made 0 purchases and 20 sales selling 56,885 shares for an estimated $4,086,319.
- JANE HENDERSON (Chief Financial Officer) has made 0 purchases and 19 sales selling 25,500 shares for an estimated $1,928,726.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API.
$APGE Stock Hedge Fund Activity
We have seen 128 institutional investors add shares of $APGE Stock stock to their portfolio, and 68 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- JANUS HENDERSON GROUP PLC added 1,576,626 shares (+324.4%) to their portfolio in Q4 2025, for an estimated $119,003,730
- T. ROWE PRICE INVESTMENT MANAGEMENT, INC. added 1,554,546 shares (+107879.7%) to their portfolio in Q4 2025, for an estimated $117,337,132
- FMR LLC added 1,308,576 shares (+18.9%) to their portfolio in Q4 2025, for an estimated $98,771,316
- BLACKROCK, INC. added 1,097,968 shares (+40.9%) to their portfolio in Q4 2025, for an estimated $82,874,624
- PERCEPTIVE ADVISORS LLC added 978,662 shares (+72.4%) to their portfolio in Q4 2025, for an estimated $73,869,407
- BRAIDWELL LP removed 863,678 shares (-60.0%) from their portfolio in Q4 2025, for an estimated $65,190,415
- VANGUARD GROUP INC added 612,193 shares (+27.3%) to their portfolio in Q4 2025, for an estimated $46,208,327
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API.
$APGE Stock Analyst Ratings
Wall Street analysts have issued reports on $APGE in the last several months. We have seen 4 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- BTIG issued a "Buy" rating on 01/06/2026
- Stephens & Co. issued a "Overweight" rating on 12/17/2025
- Deutsche Bank issued a "Buy" rating on 12/10/2025
- Craig-Hallum issued a "Buy" rating on 11/03/2025
To track analyst ratings and price targets for $APGE Stock, check out Quiver Quantitative's $APGE forecast page.
$APGE Stock Price Targets
Multiple analysts have issued price targets for $APGE recently. We have seen 11 analysts offer price targets for $APGE in the last 6 months, with a median target of $109.0.
Here are some recent targets:
- Joseph Catanzaro from Mizuho set a target price of $110.0 on 03/30/2026
- Seamus Fernandez from Guggenheim set a target price of $160.0 on 03/24/2026
- Geoff Meacham from Citigroup set a target price of $125.0 on 03/24/2026
- Edward Nash from Canaccord Genuity set a target price of $130.0 on 03/24/2026
- Julian Harrison from BTIG set a target price of $137.0 on 03/23/2026
- Danielle Brill from Truist Securities set a target price of $83.0 on 03/18/2026
- Brian Abrahams from RBC Capital set a target price of $82.0 on 03/03/2026
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
